Literature DB >> 19230153

Efficacy and effectiveness of influenza vaccination.

Kristin L Nichol1.   

Abstract

Influenza is a major causeof morbidity and mortality. Vaccination remains the most important means of preventing and controlling influenza. A review of the published literature shows that vaccination of children, healthy younger adults, the elderly, and both children and adults with high-risk medical conditions provides substantial benefits, although the types of benefits vary by age. Vaccination also generally provides benefit even during poor match seasons. Strategies to reduce transmission within households and communities throughthe vaccination of school children and to reduce transmission within health care settings through the vaccination of healthcare workers are also promising. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19230153     DOI: 10.1016/j.vaccine.2008.07.048

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  47 in total

Review 1.  Seasonal influenza vaccination campaigns for health care personnel: systematic review.

Authors:  Po-Po Lam; Larry W Chambers; Donna M Pierrynowski MacDougall; Anne E McCarthy
Journal:  CMAJ       Date:  2010-07-19       Impact factor: 8.262

Review 2.  Influenza vaccines: from surveillance through production to protection.

Authors:  Pritish K Tosh; Robert M Jacobson; Gregory A Poland
Journal:  Mayo Clin Proc       Date:  2010-01-29       Impact factor: 7.616

3.  Dispelling myths held by parents about the influenza vaccine.

Authors:  N Le Saux
Journal:  Paediatr Child Health       Date:  2009-11       Impact factor: 2.253

4.  Low-Cost Intervention to Increase Influenza Vaccination Rate at a Comprehensive Cancer Center.

Authors:  Petros D Grivas; Sumana Devata; Rami Khoriaty; Philip S Boonstra; Joshua Ruch; Kevin McDonnell; Leonel Hernandez-Aya; Joshua Wilfong; Jeffrey Smerage; Michael G Ison; Joseph N S Eisenberg; Maria Silveira; Kathleen A Cooney; Francis P Worden
Journal:  J Cancer Educ       Date:  2017-12       Impact factor: 2.037

5.  Safety and immunogenicity of influenza whole inactivated virus vaccines: A phase I randomized clinical trial.

Authors:  Renée A J van Boxtel; Pauline Verdijk; Otto J de Boer; Elly van Riet; Tjeert T Mensinga; Willem Luytjes
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  Protecting our patients by protecting ourselves: An analysis of the personal influenza immunization rate of Ontario community pharmacists.

Authors:  Blake Ziegler; Wasem Alsabbagh; Sherilyn Houle; Lisa Wenger; Dana Church; Nancy Waite
Journal:  Can Pharm J (Ott)       Date:  2016-05-27

7.  Inactivated and live, attenuated influenza vaccines protect mice against influenza: Streptococcus pyogenes super-infections.

Authors:  Michael S Chaussee; Heather R Sandbulte; Margaret J Schuneman; Frank P Depaula; Leslie A Addengast; Evelyn H Schlenker; Victor C Huber
Journal:  Vaccine       Date:  2011-04-08       Impact factor: 3.641

Review 8.  Infants and the seasonal influenza vaccine. A global perspective on safety, effectiveness, and alternate forms of protection.

Authors:  Leah F Moriarty; Saad B Omer
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

9.  Willingness to accept H1N1 pandemic influenza vaccine: a cross-sectional study of Hong Kong community nurses.

Authors:  Samuel Y S Wong; Eliza L Y Wong; Josette Chor; Kenny Kung; Paul K S Chan; Carmen Wong; Sian M Griffiths
Journal:  BMC Infect Dis       Date:  2010-10-29       Impact factor: 3.090

Review 10.  Recommended immunization schedules for adults: Clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid).

Authors:  Susanna Esposito; Paolo Bonanni; Stefania Maggi; Litjan Tan; Filippo Ansaldi; Pier Luigi Lopalco; Ron Dagan; Jean-Pierre Michel; Pierre van Damme; Jacques Gaillat; Roman Prymula; Timo Vesikari; Cristina Mussini; Uwe Frank; Albert Osterhaus; Lucia Pastore Celentano; Marta Rossi; Valentina Guercio; Gaetan Gavazzi
Journal:  Hum Vaccin Immunother       Date:  2016-05-02       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.